Webinar: Ticagrelor removal by CytoSorb

Intensive Care

Ticagrelor removal by CytoSorb in patients with acute coronary syndrome – clinical benefits and scientific results.
Priv. Doz. Dr. med. Stephan Geidel
Chief Senior Physician Cardiac Surgery – Asklepios Klinik St. Georg, Hamburg

Budget impact analysis of CytoSorb therapy in emergency open-heart surgery patients receiving Ticagrelor (Brillique).
Daniel Adam Blanco
Manager Health Economics – CytoSorbents Europe GmbH, Berlin

Webinar: Ticagrelor removal by CytoSorb

October 22, 2020
Intensive Care

Budget impact analysis of CytoSorb therapy in emergency open-heart surgery patients receiving Ticagrelor (Brillique).
Daniel Adam Blanco
Manager Health Economics – CytoSorbents Europe GmbH, Berlin

BACK TO MEDIACENTER

More Videos

CytoSorbents Introduction | EACTS 2020

Mitral valve endocarditis – new chances to improve the outcome | Daniel Wendt | EACTS 2020

Aortic surgery – modulation of the inflammatory response | Yatin Mehta | EACTS 2020

Removal of Ticagrelor during emergency heart surgery | Stephan Geidel | EACTS 2020

Successful treatment of rhabdomyolysis following heart transplantation | Udo Boeken | EACTS 2020